Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Friedrich Haag

Showing results (121-130 of 143) with videos related to

Pageof 15
Sort By:
Journal of the American Society of Nephrology : JASN|June 1, 2007
Chemokine receptor CXCR3 mediates T cell recruitment and tissue injury in nephrotoxic nephritis in miceUlf Panzer, Oliver M Steinmetz, Hans-Joachim Paust, et al.
Journal for Immunotherapy of Cancer|December 22, 2022
TIGIT blockade repolarizes AML-associated TIGIT<sup>+</sup> M2 macrophages to an M1 phenotype and increases CD47-mediated phagocytosisFranziska Brauneck, Brit Fischer, Marius Witt, et al.
Cellular Immunology|September 20, 2005
A panel of monoclonal antibodies recognizing GPI-anchored ADP-ribosyltransferase ART4, the carrier of the Dombrock blood group antigensInes Parusel, Sarah Kahl, Fenja Braasch, et al.
Cells|February 5, 2020
Targeting CD38-Expressing Multiple Myeloma and Burkitt Lymphoma Cells In Vitro with Nanobody-Based Chimeric Antigen Receptors (Nb-CARs)Julia Hambach, Kristoffer Riecken, Sophia Cichutek, et al.
Frontiers in Pharmacology|October 27, 2022
Effective targeting of microglial P2X7 following intracerebroventricular delivery of nanobodies and nanobody-encoding AAVsCarolina Pinto-Espinoza, Charlotte Guillou, Björn Rissiek, et al.
Scientific Reports|January 20, 2015
Selection of nanobodies that block the enzymatic and cytotoxic activities of the binary Clostridium difficile toxin CDTMandy Unger, Anna Marei Eichhoff, Lucas Schumacher, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 26, 2020
Sustained Response After Remdesivir and Convalescent Plasma Therapy in a B-Cell-Depleted Patient With Protracted Coronavirus Disease 2019 (COVID-19)Jakob Malsy, Luzia Veletzky, Janna Heide, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 12, 2014
Function of the Th17/interleukin-17A immune response in murine lupus nephritisTilman Schmidt, Hans-Joachim Paust, Christian F Krebs, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 19, 2022
Humoral and Cellular Immune Response After Third and Fourth SARS-CoV-2 mRNA Vaccination in Liver Transplant RecipientsAenne Harberts, Golda M Schaub, Darius F Ruether, et al.
Allergy|February 2, 2026
Novel Bispecific Engagers Targeting the CεmX Domain of mIgE-Expressing CellsConstantin Möller, Julia Hambach, Alessa Zoe Schaffrath, et al.
Pageof 15

Showing results (121-130 of 143) with videos related to

Sort By:
Pageof 15
Journal of the American Society of Nephrology : JASN|June 1, 2007
Chemokine receptor CXCR3 mediates T cell recruitment and tissue injury in nephrotoxic nephritis in miceUlf Panzer, Oliver M Steinmetz, Hans-Joachim Paust, et al.
Journal for Immunotherapy of Cancer|December 22, 2022
TIGIT blockade repolarizes AML-associated TIGIT<sup>+</sup> M2 macrophages to an M1 phenotype and increases CD47-mediated phagocytosisFranziska Brauneck, Brit Fischer, Marius Witt, et al.
Cellular Immunology|September 20, 2005
A panel of monoclonal antibodies recognizing GPI-anchored ADP-ribosyltransferase ART4, the carrier of the Dombrock blood group antigensInes Parusel, Sarah Kahl, Fenja Braasch, et al.
Cells|February 5, 2020
Targeting CD38-Expressing Multiple Myeloma and Burkitt Lymphoma Cells In Vitro with Nanobody-Based Chimeric Antigen Receptors (Nb-CARs)Julia Hambach, Kristoffer Riecken, Sophia Cichutek, et al.
Frontiers in Pharmacology|October 27, 2022
Effective targeting of microglial P2X7 following intracerebroventricular delivery of nanobodies and nanobody-encoding AAVsCarolina Pinto-Espinoza, Charlotte Guillou, Björn Rissiek, et al.
Scientific Reports|January 20, 2015
Selection of nanobodies that block the enzymatic and cytotoxic activities of the binary Clostridium difficile toxin CDTMandy Unger, Anna Marei Eichhoff, Lucas Schumacher, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 26, 2020
Sustained Response After Remdesivir and Convalescent Plasma Therapy in a B-Cell-Depleted Patient With Protracted Coronavirus Disease 2019 (COVID-19)Jakob Malsy, Luzia Veletzky, Janna Heide, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 12, 2014
Function of the Th17/interleukin-17A immune response in murine lupus nephritisTilman Schmidt, Hans-Joachim Paust, Christian F Krebs, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 19, 2022
Humoral and Cellular Immune Response After Third and Fourth SARS-CoV-2 mRNA Vaccination in Liver Transplant RecipientsAenne Harberts, Golda M Schaub, Darius F Ruether, et al.
Allergy|February 2, 2026
Novel Bispecific Engagers Targeting the CεmX Domain of mIgE-Expressing CellsConstantin Möller, Julia Hambach, Alessa Zoe Schaffrath, et al.
Pageof 15